In addition, because uniform tumor genotyping (e.g., RAS, BRAF, TP53, TERT) was not systematically performed for our retrospective cohort, future multicenter prospective registries should address this gap to clarify genotype–phenotype relationships in PDTC. The gene discussed is BRAF; the disease is neoplasm.